Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology!
作者信息
Sengul Ilker, Sengul Demet
机构信息
Giresun University, Faculty of Medicine, Division of Endocrine Surgery - Giresun, Turkey.
Giresun University, Faculty of Medicine, Department of General Surgery - Giresun, Turkey.
出版信息
Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20231511. doi: 10.1590/1806-9282.20231511. eCollection 2024.
Abstract
摘要
相似文献
1
Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology!伊万吉利，2023年《贝塞斯达甲状腺细胞病理学报告系统》已公布了亚分类：甲状腺学既往不咎！
Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20231511. doi: 10.1590/1806-9282.20231511. eCollection 2024.
2
The Bethesda thyroid terminology and progress towards international agreement on thyroid FNA cytology reporting.贝塞斯达甲状腺术语以及甲状腺细针穿刺活检细胞学报告国际共识的进展。
Cytopathology. 2010 Apr;21(2):71-4. doi: 10.1111/j.1365-2303.2010.00749.x.
3
[The new system for reporting fine needle aspiration biopsies of the thyroid gland: Bethesda 2010].[甲状腺细针穿刺活检报告新系统：2010年贝塞斯达系统]
Cesk Patol. 2011 Jan;47(1):8-14.
4
A brief description of the Bethesda System for reporting thyroid fine needle aspirates.关于甲状腺细针穿刺抽吸结果报告的贝塞斯达系统的简要描述。
Hawaii Med J. 2010 Jul;69(7):176-8.
5
Malignancy Risk of Paediatric Thyroid Nodules Classified According to the Bethesda System.
Clin Endocrinol (Oxf). 2025 Oct;103(4):497-503. doi: 10.1111/cen.15280. Epub 2025 May 28.
6
Following the steps of Abu al-Qasim to Bethesda and beyond: the continuing deliberations in thyroid fine-needle aspiration.
Diagn Cytopathol. 2012 May;40 Suppl 1:E1-3. doi: 10.1002/dc.22856. Epub 2012 Apr 17.
7
The Bethesda System for Reporting Thyroid Cytopathology.《甲状腺细胞病理学报告的贝塞斯达系统》
Thyroid. 2009 Nov;19(11):1159-65. doi: 10.1089/thy.2009.0274.
8
Ultrasound-guided thyroid fine-needle aspiration and concurrent core needle biopsy: A comparative study with practical clinical scenarios.超声引导下甲状腺细针穿刺及同期粗针活检：一项结合实际临床场景的对比研究。
Am J Clin Pathol. 2025 Sep 9;164(3):500-512. doi: 10.1093/ajcp/aqaf079.
9
The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children.《甲状腺细胞病理学报告的贝塞斯达系统》适用于儿童的冰冻切片诊断。
Pediatr Dev Pathol. 2015 Mar-Apr;18(2):139-45. doi: 10.2350/14-08-1542-OA.1. Epub 2015 Jan 27.
10
Evaluation of concordance between the Bethesda System for Reporting Thyroid Cytopathology 2023 (TBSRTC) and ACR-TIRADS at a tertiary care center in Gujarat.古吉拉特邦一家三级医疗中心对《2023年甲状腺细胞病理学报告贝塞斯达系统》（TBSRTC）与美国放射学会甲状腺影像报告和数据系统（ACR-TIRADS）之间一致性的评估。
Indian J Pathol Microbiol. 2025 Mar 13. doi: 10.4103/ijpm.ijpm_165_24.
引用本文的文献
1
Thyroid function after menopause: is there any concern in thyroidology?绝经后的甲状腺功能：甲状腺学领域是否存在相关问题？
Rev Assoc Med Bras (1992). 2024 Dec 16;70(12):e7012EDI. doi: 10.1590/1806-9282.7012EDI. eCollection 2024.
2
Thyroid tuberculosis in women: a scarce phenomenon, with predominancy in women!女性甲状腺结核：一种罕见现象，女性中更为常见！
Rev Assoc Med Bras (1992). 2024 Nov 11;70(10):e20240767. doi: 10.1590/1806-9282.20240767. eCollection 2024.
3
Is the neutrophil-to-lymphocyte "ratio"nale from head and neck to thyroidology for thyroidologists?: promise or passé?对甲状腺科医生而言，从头颈医学到甲状腺学，中性粒细胞与淋巴细胞的“比值”理论是否合理？是前景光明还是已过时？
Rev Assoc Med Bras (1992). 2024 May 20;70(5):e20231617. doi: 10.1590/1806-9282.20231617. eCollection 2024.
4
Re: "American Thyroid Association and Thyroid Imaging Reporting and Data System developed by the American College of Radiology: which one is better at predicting malignancy risk?" in thyroidology.关于：“美国甲状腺协会与美国放射学会制定的甲状腺影像报告和数据系统：哪一个在预测恶性风险方面更出色？” 甲状腺学领域相关内容
Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20231584. doi: 10.1590/1806-9282.20231584. eCollection 2024.
本文引用的文献
1
The 2023 Bethesda system for reporting thyroid cytopathology: novi sub sole, subdivision is no more debatable, in thyroidology.2023年甲状腺细胞病理学报告的贝塞斯达系统：在甲状腺学领域，“新的天地，细分不再有争议”。 （注：原文中“novi sub sole”可能有特定背景含义，这里直接按字面翻译，整体译文可能因该短语含义理解不同而稍显奇怪，需结合更多背景知识来准确把握。）
Rev Assoc Med Bras (1992). 2023 Nov 13;69(12):e20231124. doi: 10.1590/1806-9282.20231124. eCollection 2023.
2
Subdivision of intermediate suspicion, the 2021 K-TIRADS, and category III, indeterminate cytology, the 2017 TBSRTC, 2nd edition, in thyroidology: let bygones be bygones?甲状腺学中2021年K-TIRADS的中度可疑细分以及2017年第二版TBSRTC的III类、细胞学结果不确定：既往不咎？
Ultrasonography. 2023 Oct;42(4):600-601. doi: 10.14366/usg.23113. Epub 2023 Jul 25.
3
The 2023 Bethesda System for Reporting Thyroid Cytopathology.2023 年甲状腺细胞病理学报告的贝塞斯达系统。
Thyroid. 2023 Sep;33(9):1039-1044. doi: 10.1089/thy.2023.0141. Epub 2023 Jul 8.
4
Comment on: "Evaluating treatment options in managing thyroid nodules with indeterminate cytology of TBSRTC in thyroidology: addendum aut non?".关于《甲状腺学中对甲状腺影像报告和数据系统（TBSRTC）细胞学检查结果不确定的甲状腺结节进行治疗方案评估：是与否？补遗》的评论
Rev Assoc Med Bras (1992). 2022 Jul;68(7):973-974. doi: 10.1590/1806-9282.20220383.
5
Minimum minimorum: thyroid minimally invasive FNA, less is more concept? Volens nolens?最低限度：甲状腺微创细针穿刺抽吸活检，少即是多的理念？自愿还是非自愿？
Rev Assoc Med Bras (1992). 2022 Mar;68(3):275-276. doi: 10.1590/1806-9282.20211181.
6
Blurred lines for management of thyroid nodules in the era of atypia of undetermined significance/ follicular lesion of undetermined significance: novel subdivisions of categories IIIA and IIIB in a possible forthcoming The Bethesda System for Reporting Thyroid Cytopathology, 3rd edition; amending versus unnecessary?意义不明确的非典型性/意义不明确的滤泡性病变时代甲状腺结节管理的界限模糊：《甲状腺细胞病理学报告贝塞斯达系统》第3版可能即将推出的IIIA和IIIB类别的新细分；修正还是不必要？
Rev Assoc Med Bras (1992). 2021 Oct;67(10):1385-1386. doi: 10.1590/1806-9282.20210763.
7
Big gain, no pain: Thyroid minimally invasive FNA (Thy MIFNA): Proposal of novelty in terminology.大幅获益，无痛可言：甲状腺微创细针穿刺活检（Thy MIFNA）：术语创新建议
Rev Assoc Med Bras (1992). 2021 Dec;67(12):1749-1750. doi: 10.1590/1806-9282.20210922.
8
Emphasis on the novel age cutoff, 55 years, for postsurgical adjuvant radioiodine as consideration for American Thyroid Association ¾ low-intermediate risk differentiated thyroid carcinoma.
Rev Assoc Med Bras (1992). 2021 Apr;67(4):485-486. doi: 10.1590/1806-9282.20201013.
9
Focusing on thyroid nodules in suspense: 10-15 mm with repeat cytology, Category III, the Bethesda System for Reporting Thyroid Cytopathology, TBSRTC.关注可疑甲状腺结节：10 - 15毫米，需重复细胞学检查，III类，甲状腺细胞病理学报告的贝塞斯达系统（TBSRTC）
Rev Assoc Med Bras (1992). 2021 Feb;67(2):166-167. doi: 10.1590/1806-9282.67.02.20200828.
Zotero 插件